(1)
Khalid; Sania Saleem; Mohammad Eyan Khan; Unaiza Nasir; Asma Rasool Peerzada; Muhammad Usman Babar; Faizan Banaras. ROLE OF SGLT-2 INHIBITORS (GLIFLOZINS) AND CARDIORENAL OUTCOME IN PATIENTS WITH OR WITHOUT DIABETES. J Popl Ther Clin Pharmacol 2023, 30 (18), 1001-1009. https://doi.org/10.53555/jptcp.v30i18.3220.